Asthma in Australia 2005 Fig 6.6

Asthma in Australia 2005

Figure 6.6
Respiratory medications (a) supplied by wholesalers and manufacturers and (b) reimbursed prescriptions, by defined daily dose (DDD) per 1,000 persons per day, Australia, 1996–2004

Note: Respiratory medications classified according to ATC. Short-acting anticholinergics include ipratropium. Long-acting anticholinergics include tiotropium.

Sources: (a) IMS Health; (b) Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS); Australian Bureau of Statistics.

Data table

(a) Wholesale supply
	Short-acting beta agonists	Short-acting anticholinergics	Long-acting beta agonists	Long-acting anticholinergics	Cromones	Inhaled corticosteroids	Theophylline	Leukotriene receptor antagonists
1996	43.75	12.50	0.90		1.97	25.73	4.13
1997	42.10	13.38	1.38		1.98	25.74	3.52
1998	41.94	13.91	2.10		1.73	25.44	2.87	0.01
1999	42.48	14.83	3.71		1.53	25.60	2.37	0.16
2000	40.51	14.33	6.11		1.24	26.83	1.96	0.23
2001	38.43	13.44	9.71		0.99	27.65	1.62	0.23
2002	36.52	12.79	12.35		0.74	27.65	1.20	0.22
2003	34.51	9.03	13.24	2.05	0.58	25.57	0.99	0.31
2004	32.34	5.76	14.17	3.69	0.49	24.91	0.85	0.38

(b) Reimbursed prescriptions
	Short-acting beta agonists	Short-acting anticholinergics	Long-acting beta agonists	Long-acting anticholinergics	Cromones	Inhaled corticosteroids	Theophylline	Leukotriene receptor antagonists
1996	26.67	15.01			2.02	25.42	3.14
1997	26.53	15.53			2.07	25.03	2.67
1998	25.99	15.56			1.82	24.56	2.09
1999	27.34	16.40			1.64	25.90	1.64
2000	27.41	15.87	0.81		1.34	26.52	1.38
2001	26.42	14.95	4.45		1.04	27.56	1.16
2002	25.08	14.42	7.76		0.79	28.04	0.93
2003	22.77	11.13	9.45	1.73	0.60	25.57	0.80	0.08
2004	21.68	7.74	11.02	3.59	0.50	24.94	0.69	0.16